HTG Molecular Diagnostics Inc (OTCPK:HTGMQ)
$ 0.0002 -0.000199 (-99.5%) Market Cap: - Enterprise Value: -2.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2021 HTG Molecular Diagnostics Inc Earnings Call Transcript

Mar 29, 2022 / 08:30PM GMT
Release Date Price: $19.08 (+2.58%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the HTG Molecular Diagnostics, Inc. Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)

The conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to Andrew Eriksen from LifeSci Advisors. Please go ahead.

Andrew Eriksen

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding our expected revenue recovery, the importance of the company's HTG transcriptome panel, statements related to the company's HTG Therapeutics and Drug Discovery business, our future growth, business momentum and market opportunities and the expected capabilities of our technology. These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control, including uncertainties regarding the ongoing COVID-19 pandemic and its impacts on HTG and its customers that may cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot